ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

ACR Convergence 2020

November 5-9, 2020. All Virtual.

View by Number View by Title View Sessions
View by Date

Friday, November 6, 2020

9:00AM-11:00AM
Abstract Number: 0354
How Do TNF-alpha-Inhibitors in Medical History Affect Patient Reported Outcomes and Retention in Ankylosing Spondylitis Patients Treated with Secukinumab in Real World? – German Observational Study
Spondyloarthritis Including Psoriatic Arthritis – Treatment Poster I
9:00AM-11:00AM
Abstract Number: 0149
How Stable Are Medication Necessity Beliefs and Safety Concerns in the First Year of RA?
Patient Outcomes, Preferences, & Attitudes Poster I: RA, Spondyloarthritis, & OA
9:00AM-11:00AM
Abstract Number: 0002
Hydroxychloroquine and Chloroquine and Hospitalizations for Viral Infection in the Pre-COVID-19 Era
Epidemiology & Public Health Poster I: COVID-19 & Rheumatic Disease
9:00AM-11:00AM
Abstract Number: 0023
Hypophosphatasia May Be Misdiagnosed as Fibromyalgia: A Single Center Experience
Fibromyalgia & Other Clinical Pain Syndromes Poster
9:00AM-11:00AM
Abstract Number: 0039
Identification of a Regulatory Pathway Governing Expression of TRAF1 via a JIA-associated Non-coding Variant
Genetics, Genomics & Proteomics Poster
9:00AM-11:00AM
Abstract Number: 0069
Identification of CD13 as a Potential Cause for SARS-CoV-2-triggered Hyperinflammation and Thrombosis
Innate Immunity Poster
9:00AM-11:00AM
Abstract Number: 0179
Identification of Multimorbidity Patterns in Rheumatoid Arthritis Through Machine Learning
RA – Diagnosis, Manifestations, & Outcomes Poster I: Multimorbidity
9:00AM-11:00AM
Abstract Number: 0175
Identifying Immuno-phenotypes in Juvenile Localized Scleroderma with RNA Sequencing
Pediatric Rheumatology – Basic Science Poster
9:00AM-11:00AM
Abstract Number: 0371
Identifying Inadequate Response Among Ankylosing Spondylitis Patients Prescribed Biologics in a Real-world Commercially Insured Adult Population in the United States
Spondyloarthritis Including Psoriatic Arthritis – Treatment Poster I
9:00AM-11:00AM
Abstract Number: 0162
Identifying Sleep Problems in Systemic Juvenile Idiopathic Arthritis (SJIA) Patients with Patient-reported Outcomes (PRO) Questionnaires
Patient Outcomes, Preferences, & Attitudes Poster I: RA, Spondyloarthritis, & OA
9:00AM-11:00AM
Abstract Number: 0416
IgG4-related Retroperitoneal Fibrosis. Retrospective Cohort
Vasculitis – Non-ANCA-Associated & Related Disorders Poster I
9:00AM-11:00AM
Abstract Number: 0126
Immunophenotyping of Peripheral Blood Highlights an Association of Dysregulated Lymphocytes with Patients with Glucocorticoid-induced Osteonecrosis
Osteoporosis & Metabolic Bone Disease Poster
9:00AM-11:00AM
Abstract Number: 0168
Impact of Adalimumab (Humira) Therapy on Ocular Inflammation, Selected Health Care Resource Utilization, and Patient-Reported Outcomes in Patients with Active Non-infectious Intermediate, Posterior, or Panuveitis in Routine Clinical Practice
Patient Outcomes, Preferences, & Attitudes Poster I: RA, Spondyloarthritis, & OA
9:00AM-11:00AM
Abstract Number: 0220
Impact of Concomitant Glucocorticoids on the Clinical Efficacy and Safety of Upadacitinib in Patients with Rheumatoid Arthritis: An Ad Hoc Analysis of Data from Three Phase 3 Studies
RA – Treatments Poster I: RA Treatments & Their Safety
9:00AM-11:00AM
Abstract Number: 0017
Impact of COVID19 on Missed/Cancelled Rheumatology Office Visits and Parenteral Immunosuppressive Medications
Epidemiology & Public Health Poster I: COVID-19 & Rheumatic Disease
  • «Previous Page
  • 1
  • …
  • 12
  • 13
  • 14
  • 15
  • 16
  • …
  • 35
  • Next Page»
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology